Vapotherm Reports Preliminary Fourth Quarter and Full Year 2021 Revenue Results

Vapotherm Reports Preliminary Fourth Quarter and Full Year 2021 Revenue Results

Post Views: 109 Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its innovative, comfortable, non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders today announced preliminary unaudited fourth quarter and full year 2021 net revenue results. Preliminary net revenue…